HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[Transforming growth factor beta1 correlates inducible nitric oxide synthase in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension].

AbstractOBJECTIVE:
To investigate the dynamic expression of transforming growth factor beta(1)(TGF-beta(1)) and inducible nitric oxide synthase (iNOS) in pulmonary arteries of rats with hypoxia-induced pulmonary hypertension (HPH).
METHODS:
Forty adult male Wistar rats were randomly divided into five groups: a control group (C group) and groups with hypoxia for 3, 7, 14 and 21 days (H(3), H(7), H(14), H(21) group), eight rats per group. Mean pulmonary arterial pressure (mPAP), vessel morphometry and right ventricle hypertrophy index (RVHI) were measured. Lungs were inflation fixed for in situ hybridization and immunohistochemistry.
RESULTS:
mPAP increased significantly in H(7) group [(18.41 +/- 0.37) mm Hg, 1 mm Hg = 0.133 kPa, P < 0.05], reaching its peak in H(14) group [(21.17 +/- 0.23) mm Hg], then remained at the high level. Hypoxia induced pulmonary artery remodeling and right ventricle hypertrophy index became evident in H(14) group. Expression of iNOS protein in control group (0.109 +/- 0.021) was weakly positive in pulmonary arterial tunica media, while the level of iNOS protein was markedly up-regulated in H(3) group (0.225 +/- 0.030, P < 0.01), reaching its peak in H(7) group (0.312 +/- 0.036), then remained at the high level. Expression of iNOS mRNA in C group (0.112 +/- 0.030) was weakly positive in pulmonary arterial wall, while the level of iNOS mRNA was markedly up-regulated in H(3) group (0.245 +/- 0.036), reaching its peak in H(7) group (0.318 +/- 0.034, P < 0.01), then remained at the high level. Expression of TGF-beta(1) protein in C group (0.042 +/- 0.012) was weakly positive, but the level of TGF-beta(1) protein was markedly up-regulated in H(3) group (0.198 +/- 0.031), reaching its peak in H(7) group (0.267 +/- 0.035, P < 0.01), and then tended to decline in H(14) and H(21) group. TGF-beta(1) mRNA staining was weakly positive in C group (0.145 +/- 0.018), H(3) group (0.163 +/- 0.021) and H(7) group (0.176 +/- 0.026), but began to increase significantly in H(14) group (0.385 +/- 0.028, P < 0.01), and then remained stable. TGF-beta(1) protein and mRNA were located predominantly in tunica adventitia and tunica media. Linear correlation analysis showed that TGF-beta(1) mRNA, iNOS mRNA and protein were positively correlated with mPAP, vessel morphometry and RVHI (r = 0.843 - 0.937, all P < 0.01). TGF-beta(1) protein (tunica adventitia) was negatively correlated with iNOS mRNA and protein (r = -0.856, -0.835, all P < 0.01).
CONCLUSIONS:
Interaction of TGF-beta(1) and iNOS plays a role in the pathogenesis of HPH in rats. iNOS can regulate the expression of TGF-beta(1) gene by NO. TGF-beta(1) can regulate the expression of iNOS gene by decreased stability and translation of iNOS mRNA and increased degradation of iNOS protein.
AuthorsYong-liang Jiang, Ai-guo Dai, Qi-fang Li, Rui-cheng Hu
JournalZhonghua jie he he hu xi za zhi = Zhonghua jiehe he huxi zazhi = Chinese journal of tuberculosis and respiratory diseases (Zhonghua Jie He He Hu Xi Za Zhi) Vol. 28 Issue 7 Pg. 453-7 (Jul 2005) ISSN: 1001-0939 [Print] China
PMID16115393 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • RNA, Messenger
  • Transforming Growth Factor beta1
  • Nitric Oxide Synthase Type II
  • Nos2 protein, rat
Topics
  • Animals
  • Hypertension, Pulmonary (etiology, metabolism)
  • Hypoxia (complications)
  • Male
  • Nitric Oxide Synthase Type II (metabolism)
  • RNA, Messenger (genetics)
  • Rats
  • Rats, Wistar
  • Transforming Growth Factor beta1 (metabolism)
  • Up-Regulation

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: